Abstract

Next generation sequencing techniques are currently revealing novel insight into the microbiome of the human gut. This new area of research seems especially relevant for neonatal diseases, because the development of the intestinal microbiome already starts in the perinatal period and preterm infants with a still immature gut associated immune system may be harmed by a dysproportional microbial colonization. For most gastrointestinal diseases requiring pediatric surgery there is very limited information about the role of the intestinal microbiome. This review aims to summarize the current knowledge and outline future perspectives for important pathologies like necrotizing enterocolitis (NEC) of the newborn, short bowel syndrome (SBS), and Hirschsprung’s disease associated enterocolitis (HAEC). Only studies applying next generation sequencing techniques to analyze the diversity of the intestinal microbiome were included. In NEC patients intestinal dysbiosis could already be detected prior to any clinical evidence of the disease resulting in a reduction of the bacterial diversity. In SBS patients the diversity seems to be reduced compared to controls. In children with Hirschsprung’s disease the intestinal microbiome differs between those with and without episodes of enterocolitis. One common finding for all three diseases seems to be an overabundance of Proteobacteria. However, most human studies are based on fecal samples and experimental data question whether fecal samples actually represent the microbiome at the site of the diseased bowel and whether the luminal (transient) microbiome compares to the mucosal (resident) microbiome. In conclusion current studies already allow a preliminary understanding of the potential role of the intestinal microbiome in pediatric surgical diseases. Future investigations could clarify the interface between the intestinal epithelium, its immunological competence and mucosal microbiome. Advances in this field may have an impact on the understanding and non-operative treatment of such diseases in infancy.

Highlights

  • The development of the human microbiome seems to start in the prenatal period as fetuses may have contact to microorganisms already in utero (Jimenez et al, 2008; Donnet-Hughes et al, 2010; Ardissone et al, 2014)

  • The gut microbiome plays an important role during the physiological development: It is extremely important for the differentiation of gut epithelium, interacts closely with the gut-associated lymphoid tissue and influences activity and morphology of the gastrointestinal tract (Cebra, 1999; Cho and Blaser, 2012; Guaraldi and Salvatori, 2012; Hooper et al, 2012; Putignani et al, 2014)

  • One challenge associated with studies of the microbiome in pediatric surgical diseases like necrotizing enterocolitis (NEC), short bowel syndrome (SBS), and Hirschsprung’s disease associated enterocolitis (HAEC) is the low incidence of these diseases

Read more

Summary

Introduction

The development of the human microbiome seems to start in the prenatal period as fetuses may have contact to microorganisms already in utero (Jimenez et al, 2008; Donnet-Hughes et al, 2010; Ardissone et al, 2014). The major microbial colonization of the human body starts at birth: During delivery, by passing the mother’s birth canal, the babies acquire a possibly optimized set of microorganisms. The human development until the age of three is characterized by a highly sensitive interplay between microorganisms and the body. Formula feeding, treatment with antibiotics or mode of delivery (Dominguez-Bello et al, 2011; Cho et al, 2012) may have a direct impact on microbial abundance and diversity

Objectives
Findings
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.